Gandras Visci-G Catheter

COMPANY  Vascular Solutions, Inc.

PHONE  (763) 656-430

WEB  www.vasc.com

KEY FEATURES

  • Shorter overall length and distal tip to facilitate precise and stable arterial placement in the visceral vascular territories
  • Unique primary curve and a flexible 1-cm tip
  • Tight primary curve allows for easy access of bilateral arteries through a single 5-F arterial introducer

Vascular Solutions, Inc. (Minneapolis, MN) recently launched the Gandras Visci-G catheter for use in delivering embolic materials and radiopaque media to selected sites in visceral vascular territories. The Gandras Visci-G is a 5-F, 75-cm catheter with a unique primary curve and a flexible 1-cm tip, making it useful for precise and stable placement in renal, mesenteric, or abdominal catheterization procedures. The tight primary curve allows for easy access of bilateral arteries through a single 5-F arterial introducer, and standard microcatheters can then be delivered through the Visci-G catheter to access distal regions.

The Gandras Visci-G catheter can be used in clinical cases such as gastrointestinal hemorrhages, endograft leaks, and for any time operators are having difficulty seating a catheter in an artery that branches off the aorta. The new Gandras Visci-G is now available in markets worldwide.


Conformable Gore TAG Thoracic Endoprosthesis

COMPANY  W. L. Gore & Associates, Inc

PHONE  (800) 437-8181 or (928) 779-2771

WEB  www.vasc.com

KEY FEATURES

  • The only TEVAR device specifically designed and indicated for treating all isolated lesions in the thoracic aorta including aneurysms, transections, and penetrating aortic ulcers
  • Designed to treat young trauma patient anatomy
  • The only device indicated to treat aortic diameters as small as 16 mm
  • Unique 6% to 33% oversizing window allows treatment of tapered aortas with a single, straight device
  • Tapered devices available for extremely tapered aortas
  • 16- to 42-mm vessel diameters can be treated with as few as five sizes

W. L. Gore & Associates, Inc. (Flagstaff, AZ) has received US Food and Drug Administration approval for endovascular repair of isolated lesions of the descending thoracic aorta, including traumatic aortic transections, with its Conformable Gore TAG thoracic endoprosthesis. The durable endoprosthesis is the first such device to receive approval for an indication that includes traumatic transection.

Mark Farber, MD, served as National Principal Investigator for the Conformable Gore TAG Device in the Traumatic Aortic Transection trial. According to Dr. Farber, “We gained a great deal of insight and knowledge from the traumatic transection trial for the Conformable Gore TAG device that ultimately led to the expansion of indications. Through the research, we were able to illustrate the capabilities of the Conformable Gore TAG device and help to demonstrate that thoracic endografts can offer patients with traumatic aortic transection a lessinvasive alternative to open surgical repair.”



CloverSnare 4-Loop Vascular Retriever

COMPANY  Cook Medical

PHONE  (800) 457-4500

WEB  www.cookmedical.com

KEY FEATURES

  • 6-F nitinol snare with tantalum braid facilitates visibility and torque control
  • Distal end of snare catheter is slightly angled for directional control
  • Radiopaque bands mark distal ends of 8-F inner and 10-F outer delivery sheaths
  • Hemostasis valve included on inner sheath

Cook Medical (Bloomington, IN) recently received clearance from the US Food and Drug Administration to market a new vascular retrieval snare in the United States, where it will soon be commercially available. The CloverSnare 4-Loop vascular retriever will include a locking introducer dilator, an inner and outer coaxial delivery sheath set, and a 90-cm snare catheter. When fully opened, the mouth of the four-looped snare measures 29 mm at its widest point.

The CloverSnare 4-Loop vascular retriever is intended for use in the cardiovascular system to manipulate and retrieve foreign objects including, but not limited to, wire guides, coils, balloons, catheters, and filters.



EURO INNOVATIONS


Zilver Vena Venous Self-Expanding Stent

COMPANY  Cook Medical

PHONE  +353 6123 9252

WEB  www.cookmedical.com

KEY FEATURES

  • Available in 14- and 16-mm diameters and 60-, 100-, and 140-mm lengths
  • Compatible with 7-F introducer sheaths/9-F guiding catheters
  • Deployed via 80- and 120-cm delivery systems
  • Four gold markers on each end

Cook Medical (Bloomington, IN) recently received CE Mark approval for its Zilver Vena venous self-expanding stent. The stent is the first of its kind that is specifically designed to meet the challenges of iliofemoral venous stenting and is indicated to treat symptomatic iliofemoral venous outflow obstruction.

The Zilver Vena stent is based on the company's existing Zilver technology and is designed to address many of the challenges of stenting diseased veins. The Zilver Vena is a flexible, self-expanding stent that is made with shape-memory nitinol.

The Zilver Vena venous self-expanding stent is approved for sale in Europe, Australia, and New Zealand. It is not approved for sale in any other regulatory jurisdictions.